SCHEMBL25515218

SCHEMBL25515218

C[C@@H](N)[C@@H](O)c1cc2ccccn2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.50
LMNA P02545 4/20 0.50
HIF1A Q16665 3/20 0.50
ADRA2A P08913 1/20 0.50
ADRA2C P18825 1/20 0.50
ALDH1A1 P00352 3/20 0.49
ADRB1 P08588 1/20 0.44
MIF P14174 1/20 0.44
HTR2A P28223 1/20 0.44
ADRA1A P35348 1/20 0.44
HTR2B P41595 1/20 0.44
MAPT P10636 5/20 0.41
RECQL P46063 4/20 0.41
TDP1 Q9NUW8 4/20 0.41
POLB P06746 3/20 0.41
ALOX15 P16050 2/20 0.41
KMT2A Q03164 2/20 0.41
TSHR P16473 1/20 0.41
NFKB1 P19838 1/20 0.41
THPO P40225 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25515221 1.00 KDM4E (0.50) KDM4ELMNAHIF1AADRA2AADRA2C
SCHEMBL25515216 1.00 KDM4E (0.50) KDM4ELMNAHIF1AADRA2AADRA2C
SCHEMBL25515219 1.00 KDM4E (0.50) KDM4ELMNAHIF1AADRA2AADRA2C
SCHEMBL25515231 1.00 KDM4E (0.50) KDM4ELMNAHIF1AADRA2AADRA2C
SCHEMBL25515232 1.00 KDM4E (0.50) KDM4ELMNAHIF1AADRA2AADRA2C
SCHEMBL25515220 1.00 KDM4E (0.50) KDM4ELMNAHIF1AADRA2AADRA2C
SCHEMBL1645600 0.79 NPC1 (0.47) KDM4EALDH1A1MAPTPOLBALOX15
SCHEMBL25169307 0.75 MAPT (0.38) KDM4EALDH1A1MAPTPOLBALOX15
SCHEMBL25514619 0.75 MAPT (0.40) KDM4ELMNAHIF1AADRA2AADRA2C
SCHEMBL17372792 0.75 SMN1; SMN2 (0.40) KDM4EALDH1A1MAPTPOLBALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023081306-A1 INDOLIZINE COMPOUNDS FOR THE TREATMENT OF MENTAL DISORDERS OR MENTAL ENHANCEMENT TACTOGEN INC (US) 2023-05-11 WO disclosed